510(k) device
ReWalk P6.0
Re Walk Robotics , Ltd. · Powered Exoskeleton (PHL, Class II) · First FDA decision May 26, 2020, newest Mar 2, 2023Mobility impairmentSpinal cord injury and paralysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
Breakthrough-designated
Device trials
0
Naming "ReWalk P6.0"
MAUDE reports
0
Brand "ReWalk P6.0", since 2015
PubMed studies
0
Mentioning "ReWalk P6.0"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- ReWalk P6.0Breakthrough510(k)
K221696 · Decided Mar 2, 2023 · 265 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
- ReWalk P6.0510(k)
K200032 · Decided May 26, 2020 · 140 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ReWalk P6.0", any status and sponsor, newest update first.
No registered device study names "ReWalk P6.0".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ReWalk P6.0", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PHL
57 reports: 7 malfunction, 50 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1553-2021 · Started Feb 28, 2020
Reason given: ReWalk Robotics received two complaints (one in the US; one in the Germany), which alleged that the ReWalk device waistpack (which is the location of the Li-Ion battery packs) caught fire while being charged.
Cause as FDA categorized it: Device Design · Device type: Powered Exoskeleton (PHL)
Published research
The most relevant PubMed records for "ReWalk P6.0"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PHL.
- Indego(R)Parker-Hannifin Corporation · 510(k) 2018
- Atalante XWandercraft SAS · 510(k) 2025
- EksoNREkso Bionics, Inc. · 510(k) 2022
- HAL for Medical Use(Lower Limb type)Cyberdyne, Inc. · 510(k) 2020
- Ekso (version 1.1) and Ekso GT (version 1.2)Ekso Bionics, Inc. · 510(k) 2016
- Trexo TheoTrexo Robotics, Inc. · 510(k) 2026
- EveWandercraft SAS · 510(k) 2026
- ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.